CEA/CA72-4 levels in peritoneal lavage fluid are predictive factors in patients with gastric carcinoma
- 294 Downloads
Increased levels of tumor marker in intra-operative peritoneal lavage are associated with an earlier detection of recurrent peritoneal dissemination.
Intra-operative peritoneal lavage samples from 193 patients with gastric cancer were obtained to determine the levels of the tumor markers, carcinoembryonic antigen (CEA) and cancer-related antigen 72-4 (CA72-4) using a chemiluminescent enzyme immunoassay.
The peritoneal lavage CEA (CY-CEA), CA72-4 (CY-CA72-4) and serosal invasion were independent factors predicting the peritoneal dissemination including CY(+). The patients were divided into four groups on the basis of peritoneal lavage tumor marker status; group A: CY-CEA (−), CY-CA72-4 (−) group (CEA < 0.5 ng/ml, CA72-4 < 1.3 U/ml); group B: CY-CEA (−), CY-CA72-4 (+) group (CEA < 0.5 ng/ml, CA72-4 ≥ 1.3 U/ml); group C: CY-CEA (+), CY-CA72-4 (−) group (CEA ≥ 0.5 ng/ml, CA72-4 < 1.3 U/ml); and group D: CY-CEA (+), CY-CA72-4 (+) group (CEA ≥ 0.5 ng/ml, CA72-4 ≥ 1.3 U/ml). The 5-year survival among the patients in groups A, B, C and D was 87, 68, 38 and 20 %, respectively (p < 0.0001).
Combined analysis of these markers is therefore considered to be helpful for accurately determining sites of recurrence and the prognosis in advanced gastric cancer patients.
KeywordsTumor marker Tumor recurrence Gastric cancer Peritoneal dissemination Prognosis
Peritoneal lavage cytological positive
Cancer-related antigen 72-4
Cancer antigen 125
The peritoneal lavage carcinoembryonic antigen
The peritoneal lavage cancer-related antigen 72-4
Conflict of interest
The authors declare no conflicts of interest.
- Ikeguchi M, Katano K, Saitou H, Tsujitani S, Maeta M, Kaibara N (1997) Pre-operative serum levels of CA72-4 in patients with gastric adenocarcinoma. Hepatogastroenterol 44:866–871Google Scholar
- Sobin LH, Wittekind CH (1997) International Union Against Cancer: TNM classification of malignant tumors, 5th edn. Wiley, New YorkGoogle Scholar
- Sougioultzis S, Syrios J, Xynos ID, Bovaretos N, Kosmas C, Sarantonis J et al (2011) Palliative gastrectomy and other factors affecting overall survival in stage IV gastric adenocarcinoma patients receiving chemotherapy: a retrospective analysis. Eur J Surg Oncol 37:312–318CrossRefPubMedGoogle Scholar